Just over a year after taking over the helm of Ranbaxy Laboratories, Atul Sobti has said he will quit as CEO and Managing Director of the Gurgaon-based drug-maker, citing “substantial and basic” differences with the management of parent Daiichi Sankyo.
Advertisement
अगला पेज लोड हो रहा है. कृपया इंतजार करें...
